BioSpace News Archive

Liquid biopsies are thought to have many advantages over tumor biopsies.

A new technical service offered by the Frederick National Laboratory for Cancer Research will help researchers screen their nanoformulations for the risk of causing infusion reactions.

Narayan is a senior scientist and group lead at the Center for Molecular Microscopy.

As a deadly mystery disease with an unknown etiology caused worldwide panic in the early 1980s and quickly became an epidemic, Dr. Jeffrey Lifson was right in the middle of it.

More than 20 abstracts by FNL investigators will be presented in mini symposia, late-breaking research and poster sessions throughout the March 29 to April 3 meeting at the Georgia World Congress Center.

Drs. Dmitrovsky, Sharpless, and Lowy contend that the Frederick National Laboratory is a little-known entity to the cancer research community, but it “could be a great part of its discovery arsenal.”

Cayman Chemical, an industry-leading supplier of bioactive lipids, analytical standards, and contract lipidomic services, announced today that it has acquired Matreya, LLC, a lipid biochemical company located in State College, Pennsylvania, with strengths in synthesis, extraction, and purification of natural products

Mott FLP 515 Series filters are designed for filtration of low vapor pressure gases generated from a mixture of liquid chemical or solid sources. These high temperature vapors are generated in a direct liquid injection system, where the process utilizes a vaporization chamber or from a bubbler system using carrier gas.

Biotage AB (Biotage), (NASDAQ OMX Stockholm: BIOT.ST) is pleased to announce its strategic collaboration with Shandong Yingsheng Biotechnology Co., Ltd. (Yingsheng). Yingsheng is mainly focused on independently researching, producing and selling in vitro diagnostic reagents and medical equipment, building a genetic detection platform and mass spectrometry detection platform around metabolomics and genetics.

VentureMed Group, Inc., a privately-held medical device innovator in vessel preparation for interventional treatment of peripheral arterial disease and stenoses of arteriovenous fistulas and grafts, announced new data presented at the 20th Annual New Cardiovascular Horizons Annual Conference, May 29-31, in New Orleans, Louisiana.